Cargando…
Toxicities of the antifoliate, CV3717
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246827/ |
Ejemplares similares
-
Moderate antiproliferative effect of the antifolate CB3717 in the BN myeloid leukaemia model.
por: Ermens, A. A., et al.
Publicado: (1988) -
The structure of Rv3717 reveals a novel amidase from Mycobacterium tuberculosis
por: Kumar, Atul, et al.
Publicado: (2013) -
Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.
por: Curtin, N. J., et al.
Publicado: (1986) -
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer.
por: Harding, M. J., et al.
Publicado: (1988) -
Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
por: Cosentino, Francesco, et al.
Publicado: (2022)